Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
5 papers
Recent·Most cited
D. Pelizzari-Raymundo, R. Pineau, A. Papaioannou, X. Zhou, S. Martin, T. Avril, M. Le Gallo, e. chevet, E. Lafont
This study shows that IRE1 RNase activity regulates CD95 expression and cell death in cancer cells, with implications for therapeutic targeting.
bioRxiv · Feb 25, 2022Cell Biology
S. Martin, C. Heslan, G. Jegou, L. A. Eriksson, M. Le Gallo, V. Thibault, E. Chevet, F. Godey, T. Avril
This study examines the immunogenic potential of SARS-CoV-2 envelope proteins, showing that Spike and Membrane proteins elicit specific IgG, IgM, and IgA responses, with reduced Ig binding observed for the Spike G614 variant.
bioRxiv · Feb 15, 2021 · PreprintCell Biology
P.-J. Le Reste, R. Pineau, K. Voutetakis, J. Samal, G. Jegou, S. Lhomond, A. M. Gorman, A. Samali, J. B. Patterson, Q. Zeng, A. Pandit, M. AUBRY, N. Soriano, A. Etcheverry, J. Mosser, , e. chevet
The paper develops a novel immunocompetent GBM model to test the effect of IRE1 inhibition on treatment efficacy in vivo.
bioRxiv · Feb 20, 2020Cancer Biology
J. Obacz, J. Archambeau, P. J. Le Reste, R. Pineau, K. Barroso, E. Vlachavas, K. Voutetakis, T. Fainsod-Levi, A. Obiedat, Z. Granot, B. Tirosh, J. Samal, A. Pandit, J. Patterson, Q. Zheng, , e. chevet
This study identifies an IRE1-dependent proinflammatory signaling pathway in glioblastoma that promotes tumor invasion, angiogenesis, and myeloid cell infiltration.
bioRxiv · Jan 11, 2020Cancer Biology
D. Doultsinos, M. McMahon, K. Voutetakis, J. Obacz, R. Pineau, P.-J. Le Reste, A. Obiedat, J. Samal, J. B. Patterson, Q. Zheng, A. Samali, A. Pandit, B. Tirosh, A. Chatziioannou, E. Chevet, T. Avril
The paper shows that constitutive IRE1 activation maintains differentiation in glioblastoma cells by repressing stemness factors.
bioRxiv · Oct 22, 2019 · PreprintCancer Biology